Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Deciphering which businesses can sustain their high growth rates is a challenge for even the most seasoned professionals, which is why we started StockStory. That said, here are three growth stocks with significant upside potential.

Parsons (PSN)

One-Year Revenue Growth: +16.6%

Delivering aerospace technology during the Cold War-era, Parsons (NYSE: PSN) offers engineering, construction, and cybersecurity solutions for the infrastructure and defense sectors.

Why Are We Positive On PSN?

1. Impressive 23.8% annual revenue growth over the last two years indicates it’s winning market share this cycle
2. Share repurchases over the last two years enabled its annual earnings per share growth of 35.3% to outpace its revenue gains
3. Rising returns on capital show the company is starting to reap the benefits of its past investments

Parsons’s stock price of $74.40 implies a valuation ratio of 19.7x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

Super Micro (SMCI)

One-Year Revenue Growth: +82.5%

Founded in Silicon Valley in 1993 and known for its modular "building block" approach to server design, Super Micro Computer (NASDAQ: SMCI) designs and manufactures high-performance, energy-efficient server and storage systems for data centers, cloud computing, AI, and edge computing applications.

Why Are We Bullish on SMCI?

1. Annual revenue growth of 81.1% over the last two years was superb and indicates its market share increased during this cycle
2. Earnings per share grew by 23.2% annually over the last five years, massively outpacing its peers
3. Improving returns on capital reflect management’s ability to monetize investments

Super Micro is trading at $48.71 per share, or 15.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Insulet (PODD)

One-Year Revenue Growth: +23.5%

Revolutionizing diabetes care with its tubeless "Pod" technology, Insulet (NASDAQ: PODD) develops and manufactures innovative insulin delivery systems for people with diabetes, primarily through its Omnipod product line.

Why Should You Buy PODD?

1. Business is well-positioned no matter the global macroeconomic backdrop as its constant currency revenue growth averaged 26.6% over the past two years
2. Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 113% outpaced its revenue gains
3. Free cash flow margin increased by 21.9 percentage points over the last five years, giving the company more capital to invest or return to shareholders

At $305 per share, Insulet trades at 68.2x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.

High-Quality Stocks for All Market Conditions

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today